- Home
- SFST vs AURA Comparison
SFST vs AURA Comparison
Compare SFST & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- AURA
- Stock Information
- Founded
- SFST 1999
- AURA 2007
- Country
- SFST United States
- AURA United States
- Employees
- SFST N/A
- AURA N/A
- Industry
- SFST Major Banks
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- SFST Finance
- AURA Health Care
- Exchange
- SFST Nasdaq
- AURA Nasdaq
- Market Cap
- SFST 335.4M
- AURA 396.8M
- IPO Year
- SFST 1999
- AURA 2021
- Fundamental
- Price
- SFST $45.21
- AURA $6.24
- Analyst Decision
- SFST Buy
- AURA Strong Buy
- Analyst Count
- SFST 1
- AURA 7
- Target Price
- SFST $51.00
- AURA $22.29
- AVG Volume (30 Days)
- SFST 18.9K
- AURA 144.9K
- Earning Date
- SFST 10-21-2025
- AURA 11-11-2025
- Dividend Yield
- SFST N/A
- AURA N/A
- EPS Growth
- SFST 58.48
- AURA N/A
- EPS
- SFST 2.69
- AURA N/A
- Revenue
- SFST $102,878,000.00
- AURA N/A
- Revenue This Year
- SFST $8.65
- AURA N/A
- Revenue Next Year
- SFST $13.43
- AURA N/A
- P/E Ratio
- SFST $16.53
- AURA N/A
- Revenue Growth
- SFST 15.60
- AURA N/A
- 52 Week Low
- SFST $29.14
- AURA $4.35
- 52 Week High
- SFST $46.00
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- SFST 60.20
- AURA 41.77
- Support Level
- SFST $44.13
- AURA $6.20
- Resistance Level
- SFST $45.36
- AURA $6.61
- Average True Range (ATR)
- SFST 0.85
- AURA 0.28
- MACD
- SFST -0.07
- AURA 0.00
- Stochastic Oscillator
- SFST 64.14
- AURA 10.74
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.